 Drug coverage in Canada is currently fragmented and inefficient, leading to unequal access and high costs. A universal pharmacare program could address this issue by providing equitable access to necessary medications while reducing overall costs. Despite widespread support among academics, however, the implementation of such a program remains uncertain due to political and economic obstacles. This article was authored by Marc-André Gagnon.